NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY

The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an...

Full description

Saved in:
Bibliographic Details
Main Authors Mi Young CHA, Eun Joo KWAK, Tae Hee HA, Myoung Gi JO, Maeng Sup KIM, Ji Young JEON, Mi Ra KIM, Seok Jong KANG, Kwee Hyun SUH, Kwang Ok LEE, Ju Yeon LEE
Format Patent
LanguageEnglish
Spanish
Published 19.09.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient. La presente invención se refiere a un derivado de pirimidina fusionada novedosa que tiene una actividad inhibidora de tirosinas cinasas, y una composición farmacéutica para prevenir o tratar cánceres, tumores, enfermedades inflamatorias, enfermedades autoinmunes, o enfermedades mediadas inmunológicamente que comprenden el mismo como un ingrediente activo.
Bibliography:Application Number: MX20140005025